Share Bayer plummets after loss of glyphosate case

Shares of chemical giant Bayer fell by 20% on Wednesday, March 10, which has to do with the loss in a lawsuit over Roundup. The use of this drug would have caused cancer in the American who started the case.

In an initial phase of the trial, a jury in San Francisco ruled that Roundup caused the disease. In a next phase, the jury must decide on the compensation. On the other hand, Bayer is still convinced that it will not be held liable. Striking, because it is already the second case that Bayer loses. It is therefore expected that many new cases will be filed.

Bayer regrets the decision
Bayer says he regrets the decision. "This decision goes against science as science confirms that glyphosate-based herbicides do not cause cancer," the company said in a statement. In Europe, the Netherlands (with France, Hungary and Sweden) will probably the reassessment of glyphosate.

Anne-Jan Doorn

Anne Jan Doorn is an arable expert at Boerenbusiness. He writes about the various arable farming markets and also focuses on the land and energy market.

aj.doorn@boerenbusiness. Nl

© DCA Market Intelligence. This market information is subject to copyright. It is not permitted to reproduce, distribute, disseminate or make the content available to third parties for compensation, in any form, without the express written permission of DCA Market Intelligence.